Thermo Fisher Scientific Inc. (TSX:TMO)

Market Cap	310.15B
Revenue (ttm)	60.98B +3.2%
Net Income	9.16B +7.1%
EPS	24.14 +8.5%
Shares Out	n/a
PE Ratio	33.86
Forward PE	25.32
Dividend	0.06 (0.28%)
Ex-Dividend Date	Dec 15, 2025

Volume	1,849
Average Volume	2,469
Open	22.37
Previous Close	22.82
Day's Range	22.09 - 22.37
52-Week Range	14.22 - 23.30
Beta	n/a
RSI	52.10
Earnings Date	Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Laboratory Analytical Instruments
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: TMO

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD